In one single-center trial of 72 subjects using a controlled-adverse-environment model, the T4 eye drop did not meet its co-primary endpoints (ocular discomfort and inferior corneal staining) at the primary time point, but it did produce statistically significant improvements on several secondary endpoints, including central and superior corneal staining, with no adverse events reported
Unter sonst gleichen Bedingungen scheint es wahrscheinlicher, dass bei einem Produkt mit etablierter Technologie (WET) die meisten unerwarteten Nebenwirkungen abgearbeitet sind, whrend bei einer neuen Technologie mit unbewiesener Erfolgsbilanz die Wahrscheinlichkeit von unerwarteten Ereignissen grer ist
This unique peptide works at the cellular level, helping your body optimize its use of glucose and fat for energy
Synthesizing collagen 1 and 3, elastin, and glycosaminoglycans
70
After two weeks, callus formation in BPC-157 treated animals was twice as large as controls